# Stryker (SYK) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/SYK
## Company Profile
- Ticker: SYK
- Exchange: NYSE
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 303.13 USD
- Market cap: 112439711494.6 USD
- Last updated: 2026-09-04
## Business Overview
### Global MedTech Leader
Stryker is a global medical technology company offering products and services across MedSurg, Neurotechnology, and Orthopaedics. Its scale, global customer base, and product breadth make it one of the largest diversified medtech companies, with products that support surgical procedures, hospital workflows, orthopedic reconstruction, and neurotechnology care.
### MedSurg and Neurotechnology Engine
MedSurg and Neurotechnology is Stryker's largest segment, generating $3.6 billion in second-quarter 2026 net sales. Growth was driven mainly by unit volume, showing continued demand across the company's procedural and hospital-facing technology portfolio.
### Orthopaedics Franchise
Orthopaedics remains a major growth pillar, with $3.0 billion in second-quarter sales and strong organic growth. Stryker also reorganized elements of its orthopaedic instruments, neuro cranial, spine enabling technologies, and related portfolios to better align with internal reporting and business management.
### Operational Resilience
The quarter also reflected recovery from a cyber incident reported earlier in 2026. Despite that disruption, Stryker delivered strong sales, EPS, and operating cash flow growth. This supports the company's positioning as a resilient medtech operator with a steady cadence of innovation and disciplined execution.
## Why The Stock Is Moving

As of Sep 4, 2026, SYK closed down 1.58% at $303.13. No new same-company headline was identified in the current news window.

## Recent News
- 2026-08-31 20:05 EST — [Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering](https://biopharmsignal.com/news/SYK/stryker-signs-definitive-agreement-to-acquire-zurimed-to-enhance-its-shoulder-of-4eb05dbc) — Source: Stryker
- 2026-08-27 19:00 EST — [Stryker to participate in the 2026 Wells Fargo Healthcare Conference](https://biopharmsignal.com/news/SYK/stryker-to-participate-in-the-2026-wells-fargo-healthcare-conference-017c3771) — Source: Stryker
- 2026-08-05 13:34 EST — [Stryker declares an $0.88 per share quarterly dividend](https://biopharmsignal.com/news/SYK/stryker-declares-an-0-88-per-share-quarterly-dividend-a54358d7) — Source: Stryker
- 2026-07-30 20:05 EST — [Stryker reports second quarter 2026 operating results](https://biopharmsignal.com/news/SYK/stryker-reports-second-quarter-2026-operating-results-2db5f238) — Source: Stryker
- 2026-07-01 12:00 EST — [Stryker to announce second quarter 2026 financial results](https://biopharmsignal.com/news/SYK/stryker-to-announce-second-quarter-2026-financial-results-94b73874) — Source: Stryker